The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice
Open accessAbstract
The use of monoamine oxidase inhibitors (MAOIs) by psychiatrists has declined over the past several decades with the expansion of psychiatrists' pharmacologic armamentarium. This trend has also been driven by concern about food and drug interactions and side effects, as well as waning physician experience with these medications. Many psychiatrists, in fact, never prescribe MAOIs. Recent research has liberalized the MAOI diet and identified symptom presentations more likely to respond to these medications. Thus, clinicians must continue to familiarize themselves with the properties of and indications for prescribing MAOIs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.2.195 · Cited by 167
Research works printed but not linked: 117
- Kennedy, 1997, J Psychiatry Neurosci, 22, 127
- Fava, 2000, J Clin Psychiatry, 61, 26, 10.4088/JCP.v61n0107 · DOI
- Nutt, 1989, sychiatry, 154, 287
- Petersen, 2002, Prog Neuropsychopharmacol Biol Psychiatry, 26, 177, 10.1016/S0278-5846(01)00250-0 · DOI
- Olfson, 1993, Am J Psychiatry, 150, 571, 10.1176/ajp.150.4.571 · DOI
- Olfson, 1998, Arch Gen Psychiatry, 55, 310, 10.1001/archpsyc.55.4.310 · DOI · Paper page
- Pare, 1985, Br J Psychiatry, 146, 576, 10.1192/bjp.146.6.576 · DOI
- 1965, Br J Psychiatry, 1, 881
- Robinson, 1978, Arch Gen Psychiatry, 35, 629, 10.1001/archpsyc.1978.01770290111010 · DOI
- Balon, 1999, Psychiatr Serv, 50, 945, 10.1176/ps.50.7.945 · DOI
- Clary, 1990, J Clin Psychiatry, 51, 226
- Fava, 2000, J Clin Psychiatry, 61, 10
- Cooper, 1989, Br J Psychiatry, 155, 38, 10.1192/S000712500029747X · DOI
- Nierenberg, 2003, J Clin Psychiatry, 52, 383
- Zarate, 1995, J Clin Psychiatry, 56, 260
- Himmelhoch, 1991, Am J Psychiatry, 148, 910, 10.1176/ajp.148.7.910 · DOI · Paper page
- Thase, 1995, Neuropsychopharmacology, 12, 185, 10.1016/0893-133X(94)00058-8 · DOI · Paper page
- Kukopulos, 1983, Compr Psychiatry, 24, 249, 10.1016/0010-440X(83)90076-7 · DOI
- Amsterdam, 1996, Psychiatr Clin North Am, 19, 371, 10.1016/S0193-953X(05)70293-8 · DOI
- Keller, 1982, JAMA, 248, 1848, 10.1001/jama.1982.03330150034019 · DOI · Paper page
- Amsterdam, 2001, Psychiatric Annals, 31, 361, 10.3928/0048-5713-20010601-05 · DOI
- Guze, 1987, J Clin Psychiatry, 48, 31
- Davidson, 1984, J Affect Disord, 6, 201, 10.1016/0165-0327(84)90025-9 · DOI
- Ravaris, 1976, Arch Gen Psychiatry, 33, 347, 10.1001/archpsyc.1976.01770030057008 · DOI
- Tyrer, 1980, Br J Psychiatry, 136, 359, 10.1192/bjp.136.4.359 · doi:10.1192/bjp.136.4.359
- Crane, 1957, Psychiatric Research Reports, 8, 142
- West, 1959, BMJ, 1, 1491, 10.1136/bmj.1.5136.1491 · DOI · Paper page
- Schildkraut, 1964, Am J Psychiatry, 122, 509, 10.1176/ajp.122.5.509 · DOI · Paper page
- Dunlop, 1965, Psychosomatics, VI, 1, 10.1016/S0033-3182(65)72335-9 · doi:10.1016/s0033-3182(65)72335-9
- Bymaster, 2003, Expert Opin Investig Drugs, 12, 531, 10.1517/13543784.12.4.531 · DOI
- Moreno, 2000, Biol Psychiatry, 48, 327, 10.1016/S0006-3223(00)00893-3 · DOI
- Delgado, 1990, Arch Gen Psychiatry, 47, 411, 10.1001/archpsyc.1990.01810170011002 · DOI · Paper page
- Livingston, 1996, Drug Saf, 14, 218, 10.2165/00002018-199614040-00002 · DOI · Paper page
- Baker, 1992, J Psychiatr Neurosci, 17, 206
- Mallinger, 1991, Psychopharmacol Bull, 27, 493
- Davidson, 1978, Am J Psychiatry, 135, 470, 10.1176/ajp.135.4.470 · doi:10.1176/ajp.135.4.470
- Breshnahan, 1990, J Clin Psychiatry, 51, 47
- Raft, 1981, Neuropsychobiology, 7, 122, 10.1159/000117841 · DOI
- Bartholomew, 1962, Med J Aust, 49, 655, 10.5694/j.1326-5377.1962.tb26247.x · DOI
- Davidson, 1983, J Affect Disord, 5, 183, 10.1016/0165-0327(83)90012-5 · DOI
- Escobar, 1974, Am J Psychiatry, 131, 1025, 10.1176/ajp.131.9.1025 · doi:10.1176/ajp.131.9.1025
- Evans, 1982, J Clin Psychopharmacol, 2, 208, 10.1097/00004714-198206000-00007 · DOI
- Fulton, 1996, Drugs, 52, 450, 10.2165/00003495-199652030-00013 · DOI
- Fava, 2000, J Clin Psychiatry, 61, 37
- Rabkin, 1984, J Clin Psychopharmacol, 4, 270, 10.1097/00004714-198410000-00007 · DOI
- Gomez-Gil, 1996, Ann Intern Med, 124, 692, 10.7326/0003-4819-124-7-199604010-00014 · DOI
- Robinson, 2002, Psychopharmacol Bull, 36, 124
- Falon, 1988, J Clin Psychiatry, 49, 163
- Linet, 1986, J Clin Psychiatry, 47, 563
- Lavin, 1993, Biol Psychiatry, 34, 146, 10.1016/0006-3223(93)90384-P · DOI
- Fischer, 1995, J Clin Psychopharmacol, 15, 440, 10.1097/00004714-199512000-00009 · doi:10.1097/00004714-199512000-00009
- Sternbach, 1991, Am J Psychiatry, 148, 705, 10.1176/ajp.148.6.705 · DOI · Paper page
- Neuvonen, 1993, Lancet, 342, 1419, 10.1016/0140-6736(93)92774-N · DOI · Paper page
- Linden, 1984, Ann Emerg Med, 13, 1137, 10.1016/S0196-0644(84)80339-X · doi:10.1016/s0196-0644(84)80339-x
- Baker, 1999, Cell Mol Neurobiol, 19, 411, 10.1023/A:1006982732681 · doi:10.1023/a:1006982732681
- Kita, 2003, Biol Pharm Bull, 26, 386, 10.1248/bpb.26.386 · doi:10.1248/bpb.26.386
- Marangell, 2001, J Clin Psychiatry, 62, 12, 10.4088/JCP.v62n0104 · DOI · Paper page
- Gitlin, 1997, J Clin Psychopharmacol, 17, 66, 10.1097/00004714-199702000-00022 · doi:10.1097/00004714-199702000-00022
- Szuba, 1997, J Clin Psychiatry, 58, 307, 10.4088/JCP.v58n0704 · DOI
- Bodner, 1995, Neurology, 45, 219, 10.1212/WNL.45.2.219 · doi:10.1212/wnl.45.2.219
- Volz, 1998, Drugs Aging, 13, 341, 10.2165/00002512-199813050-00002 · DOI
- Noorily, 1997, South Med J, 90, 836, 10.1097/00007611-199708000-00014 · DOI
- Pope, 1985, Am J Psychiatry, 142, 491, 10.1176/ajp.142.4.491 · doi:10.1176/ajp.142.4.491
- Livingston, 1995, Lancet, 345, 533, 10.1016/S0140-6736(95)90460-3 · doi:10.1016/s0140-6736(95)90460-3
- Hammerness, 2002, Psychosomatics, 43, 248, 10.1176/appi.psy.43.3.248-a · DOI
- Sullivan, 1984, Can J Psychiatry, 29, 707, 10.1177/070674378402900814 · DOI
- Blackwell, 1963, Lancet, II, 849, 10.1016/S0140-6736(63)92743-0 · DOI · Paper page
- Blackwell, 1967, Br J Psychiatry, 113, 349, 10.1192/bjp.113.497.349 · DOI · Paper page
- Gardner, 1996, J Clin Psychiatry, 57, 99
- McCabe, 1982, J Clin Psychiatry, 43, 178
- Shulman, 1989, J Clin Psychopharmacol, 9, 397, 10.1097/00004714-198912000-00002 · DOI
- Shulman, 1999, J Clin Psychiatry, 60, 191, 10.4088/JCP.v60n0308 · DOI
- Shulman, 1997, Can J Psychiatry, 42, 310, 10.1177/070674379704200311 · doi:10.1177/070674379704200311
- Walker, 1996, J Clin Psychopharmacol, 16, 383, 10.1097/00004714-199610000-00007 · DOI
- Bieck, 1988, J Clin Psychiatry, 8, 237
- Feinberg, 2000, J Clin Psychiatry, 61, 145, 10.4088/JCP.v61n0211c · doi:10.4088/jcp.v61n0211c
- Folks, 1983, J Clin Psychopharmacol, 3, 249, 10.1097/00004714-198308000-00011 · DOI
- Neil, 1979, J Clin Psychiatry, 40, 33
- Sweet, 1995, sychiatry, 56, 196
- Clayton, 1998, J Clin Psychiatry, 59, 5
- Nierenberg, 1998, J Clin Psychiatry, 59, 5
- Liebowitz, 1993, J Clin Psychiatry, 52, 10
- Parker, 2002, Am J Psychiatry, 159, 1470, 10.1176/appi.ajp.159.9.1470 · DOI · Paper page
- Lam, 1996, Compr Psychiatry, 37, 375, 10.1016/S0010-440X(96)90020-6 · DOI
- Davidson, 1987, J Clin Psychiatry, 48, 143
- Davidson, 1986, Psychiatry Res, 17, 87, 10.1016/0165-1781(86)90063-6 · DOI
- Liebowitz, 1988, Arch Gen Psychiatry, 45, 129, 10.1001/archpsyc.1988.01800260037004 · DOI · Paper page
- Liebowitz, 1984, Arch Gen Psychiatry, 41, 669, 10.1001/archpsyc.1984.01790180039005 · DOI · Paper page
- McGrath, 1993, Am J Psychiatry, 150, 118, 10.1176/ajp.150.1.118 · DOI
- Quitkin, 1993, Br J Psychiatry, 163, 30, 10.1192/S0007125000292465 · DOI · Paper page
- Stewart, 2002, europsychopharmacology, 26, 237, 10.1016/S0893-133X(01)00313-X · DOI
- Thase, 1991, Psychopharmacol Bull, 27, 17
- Davidson, 1982, Arch Gen Psychiatry, 39, 527, 10.1001/archpsyc.1982.04290050015005 · DOI
- Paykel, 1982, Arch Gen Psychiatry, 39, 1041, 10.1001/archpsyc.1982.04290090035008 · DOI
- White, 1984, Psychopharmacology, 82, 258, 10.1007/BF00427786 · DOI
- Pande, 1996, Biol Psychiatry, 40, 1017, 10.1016/0006-3223(95)00628-1 · DOI
- Stoll, 1994, Am J Psychiatry, 151, 1642, 10.1176/ajp.151.11.1642 · DOI
- Davidson, 1988, Arch Gen Psychiatry, 45, 120, 10.1001/archpsyc.1988.01800260024003 · DOI
- Kay, 1973, Br J Psychiatry, 123, 63, 10.1192/bjp.123.1.63 · doi:10.1192/bjp.123.1.63
- Reynaert, 1995, Psychopharmacology, 118, 183, 10.1007/BF02245838 · DOI
- Georgotas, 1987, Br J Psychiatry, 151, 102, 10.1192/bjp.151.1.102 · DOI
- Georgotas, 1986, Biol Psychiatry, 21, 1155, 10.1016/0006-3223(86)90222-2 · DOI
- McGrath, 1987, Psychopharmacol Bull, 23, 169
- Himmelhoch, 1972, J Nerv Ment Dis, 155, 216, 10.1097/00005053-197209000-00009 · DOI
- Thase, 1992, J Clin Psychiatry, 53, 5
- Nolen, 1988, Acta Psychiatr, 78, 676, 10.1111/j.1600-0447.1988.tb06403.x · DOI
- Kahn, 1989, J Clin Psychopharmacol, 9, 198, 10.1097/00004714-198906000-00007 · doi:10.1097/00004714-198906000-00007
- Ebert, 1995, Psychopharmacology, 119, 342, 10.1007/BF02246301 · DOI
- Lotufo-Neto, 1999, Neuropsychopharmacology, 20, 226, 10.1016/S0893-133X(98)00075-X · DOI · Paper page
- Amsterdam, 2003, J Clin Psychiatry, 64, 208, 10.4088/JCP.v64n0216 · DOI
- Bodkin, 2002, Am J Psychiatry, 159, 1869, 10.1176/appi.ajp.159.11.1869 · DOI · Paper page
- Sunderland, 1994, Arch Gen Psychiatry, 51, 607, 10.1001/archpsyc.1994.03950080019003 · DOI
- Mann, 1989, Arch Gen Psychiatry, 46, 45, 10.1001/archpsyc.1989.01810010047007 · DOI · Paper page
- McGrath, 1989, Psychophar-macol Bull, 25, 63
- Pierre, 2000, J Clin Psychiatry, 61, 450, 10.4088/JCP.v61n0610h · DOI
- Davidson, 1982, J Clin Psychopharmacol, 2, 216, 10.1097/00004714-198206000-00010 · doi:10.1097/00004714-198206000-00010
- Nierenberg, 1990, J Clin Psychiatry, 51, 39
Cited by
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Bauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., WFSBP Task Force on Unipolar Depres, Bauer, M., Bschor, T., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 477
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
Morera, L., Lübbert, M., & Jung, M. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0223-4 · Cited by 395
A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology
Chen, H., Nwe, P.-K., Yang, Y., Rosen, C. E., Bielecka, A. A., Kuchroo, M., Cline, G. W., Kruse, A. C., Ring, A. M., Crawford, J. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.036 · Cited by 344
Metadata
- Authors
- FIEDOROWICZ, J. G., & SWARTZ, K. L.
- Venue
- Journal of Psychiatric Practice
- Published
- 2004-07
- Volume
- 10
- Issue
- 4
- Pages
- 239-248
- ISSN
- 1527-4160 (ISSN-L)
- 1538-1145
- OpenAlex
- W2038208465
- Cited by
- 164
- References
- 1
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice. https://app.cochat.ai/papers/10.1097/00131746-200407000-00005
- The paper
- FIEDOROWICZ, J. G., & SWARTZ, K. L. (2004). The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice. Journal of Psychiatric Practice. https://doi.org/10.1097/00131746-200407000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.